Latest Leverage News

Xenitra’s Hong Kong subsidiary Fukang has inked a three-year A$5 million procurement framework for specialised medical nutrition products, broadening its foothold beyond OTC medicines in China’s booming healthcare market.

Brazilian Rare Earths (ASX: BRE) has unveiled a scoping study for its Monte Alto and Camaçari project in Bahia, Brazil, showcasing ultra-high grades and robust economics with a post-tax NPV8 of US$6 billion and a rapid 1.1-year payback.

Critica Limited is reshaping its Mt Lindsay Tin-Tungsten Project with an innovative underground mining approach, aiming to reduce surface disturbance and integrate environmental and commercial factors amid strengthening commodity prices.

Aureka Limited has refreshed its geological model and confirmed multiple exploration targets at the Irvine Gold Project, underscoring the site’s significant potential beyond its current 398,000-ounce inferred resource.

Lycopodium Limited has won a A$37 million EPCM contract to develop a new silver oxide processing plant at Bolivia’s San Cristóbal Mine, aiming to boost silver production alongside existing operations.

XRF Scientific reported an 8% revenue increase to $64.4 million and a modest 1% rise in net profit after tax for FY26, underpinned by strong performances in Precious Metals and Capital Equipment divisions and the strategic acquisition of Bruker’s CGA business.

Regener8 Resources has identified significant high-grade silver, zinc, lead, and antimony mineralisation at its newly acquired Srebrenica North Project in Bosnia, with historical and recent sampling underscoring exploration potential.

Andel Resources has exercised its option to enter a binding Right to Mine Agreement with Reach Resources, committing to fully fund mining and processing at the Murchison South Gold Project in Western Australia.

Chariot Resources has inked a binding term sheet with major Chinese and Nigerian partners for a phased drilling and trial mining program targeting lithium direct shipping ore in Nigeria, aiming to validate resource potential and establish a market-linked offtake.

Aspen Group delivered a robust FY26 with 27% profit growth and an 11 cents distribution, underpinned by rental portfolio expansion and a 71% surge in development profit. The company also upgraded its FY27 guidance, supported by fresh development approvals and strategic acquisitions.

Cogstate Ltd (ASX:CGS) posted a 15.9% rise in profit before tax to US$16.1 million for FY26, driven by a 116% surge in clinical trial sales contracts to $89 million and a 15% revenue increase. The company doubled its final dividend to A$0.04 per share, supported by a strong $118.5 million contracted revenue backlog.

HUB24 Limited (ASX:HUB) delivered a standout FY26 with 23% revenue growth, 30% EBITDA increase, and record platform net inflows of $18.9 billion, while boosting dividends by 39%.